The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC).
 
Huilai Lv
No Relationships to Disclose
 
Yang Tian
No Relationships to Disclose
 
Chao Huang
No Relationships to Disclose
 
Zhenhua Li
No Relationships to Disclose
 
Ziqiang Tian
No Relationships to Disclose